Theodoros Foukakis

Pembrolizumab for Early Triple-Negative Breast Cancer

Peter Schmid, Javier Cortés, Lajos Pusztai et al. · New England Journal of Medicine · 2020 · 2.9K citations · Full text

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing

Charissa Kim, Ruli Gao, Emi Sei et al. · Cell · 2018 · 1.1K citations

Systems Biology, Oncology, Engineering +14

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression

Asís Palazón, Petros A. Tyrakis, David Macías et al. · Cancer Cell · 2017 · 512 citations · Full text

Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study

Peter Schmid, Roberto Salgado, Y.H. Park et al. · Annals of Oncology · 2020 · 423 citations

Phase 1B, Breast Oncology, Oncology +9

Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer

Peter Schmid, Javier Cortes, Rebecca Dent et al. · New England Journal of Medicine · 2024 · 310 citations · Full text